Story perspectives
Mainland Investors Boost Hong Kong Healthcare Stocks Rally
3/10/2026
1 of 1
Story summary
- Mainland Chinese investors can buy shares in thirteen healthcare firms listed in Hong Kong following a Stock Connect southbound list update.
- Additions include Insilico Medicine, a biotechnology company, and Xuanzhu Biopharmaceutical, a healthcare firm.
- Jonah Chen of China Merchants Securities notes mainland buyers drive a healthcare rally.
- The update enables mainland investors to trade Hong Kong shares through Shanghai and Shenzhen.
